Live from the NIH registry
Studies recruiting near Buffalo right now
Top 25 of 521 recruiting studies, sorted by proximity — each links to its official registry page
EMS Providers' Health Initiative Study
Shift-work Disorder
N/A
Interventional 40 participants sought
University at Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
Inhaled Isopropyl Alcohol for Treatment of Nausea
Vomiting, Nausea
Phase 2, Phase 3
Interventional 84 participants sought
Oishei Children's Hospital — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Golisano Children's Hospital of Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: The University of Texas Health Science Center, Houston
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Pediatric Cancer
N/A
Observational 35 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Buffalo, New York (1.8 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Buffalo General Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Magenta Medical Ltd.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Lyell Immunopharma, Inc.
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Plasma Cell Leukemia
Phase 2
Interventional 74 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Acute Myeloid Leukemia
Phase 2
Interventional 53 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Joshua Zeidner
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation
Phase 1
Interventional 420 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Kura Oncology, Inc.
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 1
Interventional 126 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Leukemia, Leukemia, Myeloid
Phase 1
Interventional 170 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: BlossomHill Therapeutics
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
Dent Neurological Institute — Buffalo, New York (1.8 mi)
· Sponsor: Novartis Pharmaceuticals
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Sisters of Charity Hospital — Buffalo, New York (1.8 mi)
· Sponsor: Duke University
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
Cigarette Smoking
N/A
Interventional 316 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Virginia Polytechnic Institute and State University
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
Pain
N/A
Interventional 120 participants sought
UBMD Orthopedics and Sports Medicine — Williamsville, New York (7.1 mi)
· Sponsor: Synaptrix, Inc.
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Phase 2
Interventional 80 participants sought
Vima Site #055 — Amherst, New York (5.8 mi)
· Sponsor: Vima Therapeutics
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer
Phase 3
Interventional 600 participants sought
Research Site — Buffalo, New York (1.8 mi)
· Sponsor: AstraZeneca
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: NRG Oncology
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
University of Buffalo Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Dent Neurologic Institute - Amherst /ID# 270260 — Amherst, New York (5.8 mi)
· Sponsor: AbbVie
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer
Phase 1, Phase 2
Interventional 890 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Chronic Phase Chronic Myelogenous Leukemia
Phase 2
Interventional 51 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Medical College of Wisconsin